These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 67518)

  • 21. [Pentoxifylline and intermittent claudication: critical analysis of clinical trials].
    Charansonney OL; Spriet A
    Therapie; 1995; 50(1):73-8. PubMed ID: 7754482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Walking distance and arterial flow during long term treatment of intermittent claudication with d-a-tocopherol.
    Haeger K
    Vasa; 1973; 2(3):280-7. PubMed ID: 4745137
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of nialamide in intermittent claudication.
    Johansson BW; Sievers J; Johansson S
    Angiology; 1967 Dec; 18(12):752-63. PubMed ID: 4864297
    [No Abstract]   [Full Text] [Related]  

  • 24. Further evaluation of papaverine for peripheral vascular ischemia.
    Stern FH
    J Am Geriatr Soc; 1967 Apr; 15(4):386-93. PubMed ID: 5335635
    [No Abstract]   [Full Text] [Related]  

  • 25. Peripheral arterial occlusive disease: conservative treatment of intermittent claudication.
    Kriessmann A
    J Cardiovasc Pharmacol; 1990; 16 Suppl 3():S72-4. PubMed ID: 1369724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Letter: Are vitamin E supplements beneficial?
    Med J Aust; 1974 May; 1(21):858-9. PubMed ID: 4852699
    [No Abstract]   [Full Text] [Related]  

  • 27. [Vasoactive drugs in peripheral arterial perfusion disorders. Problems, principles and results of the determination of therapeutic efficacy].
    Heidrich H
    Dtsch Med Wochenschr; 1985 Aug; 110(31-32):1219-24. PubMed ID: 3926447
    [No Abstract]   [Full Text] [Related]  

  • 28. Mortality in the CHAOS trial. Cambridge Heart Antioxidant Study.
    Ness A; Smith GD
    Lancet; 1999 Mar; 353(9157):1017-8. PubMed ID: 10459945
    [No Abstract]   [Full Text] [Related]  

  • 29. The oxidative paradox: another piece in the puzzle.
    Patterson C; Madamanchi NR; Runge MS
    Circ Res; 2000 Dec; 87(12):1074-6. PubMed ID: 11110759
    [No Abstract]   [Full Text] [Related]  

  • 30. High dose vitamin E may slow Alzheimer's decline.
    Harv Mens Health Watch; 2014 Mar; 18(8):8. PubMed ID: 24839661
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of intermittent claudication with vitamin E.
    LIVINGSTONE PD; JONES C
    Lancet; 1958 Sep; 2(7047):602-4. PubMed ID: 13588942
    [No Abstract]   [Full Text] [Related]  

  • 32. Ineffectiveness of isoxsuprine on intermittent claudication.
    Strandness DE
    JAMA; 1970 Jul; 213(1):86-8. PubMed ID: 4393178
    [No Abstract]   [Full Text] [Related]  

  • 33. The treatment of intermittent claudication with vitamin E.
    HAMILTON M; WILSON GM; ARMITAGE P; BOYD JT
    Lancet; 1953 Feb; 1(6756):367-70. PubMed ID: 13024018
    [No Abstract]   [Full Text] [Related]  

  • 34. [Free-radical lipid oxidation in the pathogenesis of myocardial infarct and the therapeutic and prophylactic role of antioxidants, sodium selenite and its combination with vitamin E].
    Kudrin AN; Kogan AKh; Korolev VV; Nikolaev SM; Beskrovnova NN
    Kardiologiia; 1978 Feb; 18(2):115-8. PubMed ID: 633712
    [No Abstract]   [Full Text] [Related]  

  • 35. A double-blind study comparing suloctidil and placebo in chronic peripheral arteriopathy.
    Gillot P
    Curr Ther Res Clin Exp; 1976 Nov; 20(5):637-44. PubMed ID: 825349
    [No Abstract]   [Full Text] [Related]  

  • 36. Adjunctive vitamin E treatment in Wilson disease and suggestions for future trials.
    Shen L; Ji HF
    Hepatology; 2010 May; 51(5):1864; author reply 1864-5. PubMed ID: 20432273
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of claudication with dipyridamole and aspirin.
    Libretti A; Catalano M
    Monogr Atheroscler; 1986; 14():207-9. PubMed ID: 3526127
    [No Abstract]   [Full Text] [Related]  

  • 38. Swan song for antioxidant supplements. IF your take antioxidants to treat or prevent heart disease, it's time to rethink this gambit.
    Harv Heart Lett; 2004 Nov; 15(3):3. PubMed ID: 15556913
    [No Abstract]   [Full Text] [Related]  

  • 39. Lack of effect of cyclandelate in peripheral arterial disease.
    Vyden JK; Nagasawa K; Kanazawa M; Rose HB; Seino Y; Groseth-Robertson MF; Lander EB; Elconin SB
    Angiology; 1984 Jan; 35(1):1-11. PubMed ID: 6364892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Ineffectiveness of Naudicelle in intermittent claudication].
    Olsson AG; Kirstein P; Eklund B; Johnsson H; Walldius G
    Lakartidningen; 1984 Dec; 81(51):4855-7. PubMed ID: 6394928
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.